With another year of double-digit revenue growth in the books, Amgen’s longtime helmsman Robert Bradway continues to sit ...
Amgen CEO Bob Bradway joins 'Mad Money' host Jim Cramer to talk its rare disease business, its weight-loss drug offering, what is in Amgen's pipeline, and more. Got a confidential news tip? We want to ...
Amgen Inc. (NASDAQ:AMGN) is included among the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds. On January 26, UBS lifted its price target on Amgen Inc. (NASDAQ:AMGN) to $390 from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results